Development of an alternative light source to lasers for photodynamic therapy: 1. Comparative in vitro dose response characteristics
Tóm tắt
The relative performances of a prototype lamp, a pulsed laser and a continous wave laser, were compared for photodynamic therapy (PDT). Recent advances in short are technology and lamp miniaturization coupled with improvements in the effciency, of optical filter coatings have led to the design and construction of a table-top light source prototype; the first viable and cost-effective alternative to a laser, particularly in the field of PDT. The device can deliver over 1 W directly or 0.5W via a light guide within a 30 nm band centred at any wavelength from the ultra-violet to the near infra-red at fluence rates of over 1 W cm−2, in excess of that required for PDT. Its relative biological effectiveness (RBE), in vitro, has been proven alongside two PDT laser systems, an argon pumped dye laser and a copper vapour pumped dye laser. These first in vitro tests showed an efficiency of haematoporphyrin derivative, (HPD) induced cellular photoinactivation close to that of the argon/dye laser (RBE 100%), with a mean RBE for the lamp of 87±3% (p<0.05). The lamp proved to be superior, to that of the copper/dye laser system with an RBE of up to 150% at fluence rates above 50 m W cm−2. Transient photobleaching of the photosensitizer was the probable cause for the relative ineffectiveness of the copper/dye laser for PDT at high fluence rates.
Tài liệu tham khảo
Dougherty TJ, Kaufman JE, Goldfarb A et al. Photoradiation therapy for the treatment of malignant tumors.Cancer Res 1978,38:2628–35
Pope AJ, Bown SG. Photodynamic therapy.Br J Urol 1991,68:1–9
Delaney TF, Sindelar WF, Tochner Z et al. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors.Int J Radiat Oncol Biol Phys 1993,25:445–57
Dahlman A, Wile AG, Burns RG et al. Laser photoradiation therapy of cancer.Cancer Res 1982,43:430–4
Pantelides ML, Whitehurst C, Moore JV et al. Photodynamic therapy for localised prostate cancer light penetration in the human prostate gland.J Urol 1990,143:398–401
Laplant M, Parker J, Stewart et al. Comparison of the optical transmission properties of pulsed and continuous wave light in biological tissues.Lasers, Surg Med 1987,7:366–8
Okunaka T, Kato H, Konaka C et al. A comparison between argon-dye and excimer-dye laser for photodynamic effect in transplantable mouse tumour.Jpn J Cancer Res 1992,83:226–31
Ferrario A, Rucker N, Ryter SW et al. Direct comparison of in vitro and in vivo photofrin II mediated photosensitisation using a pulsed KTP pumped dye laser and a continuous wave argon ion pumped dye laser.Lasers Surg Med 1991,11:404–10
Bellnier DR, Lin C-W, Parrish JA, Mock PC. Hematoporphyrin derivative and pulse laser photoradiation. In: Doiron DR, Gomer CJ (eds)Porphyrin Localisation and Treatment of Turmours. New York: Alan Liss, 1984:533–40
Barr H, Boulos PB, MacRoberts AJ et al. Comparison of lasers for photodynamic therapy with a phthalocyanine photosensitiser.Lasers Med Sci Sci, 1989,4:7–12
Forbes IJ, Ward AD, Jacka FJ et al. Multidisciplinary approach to phototherapy of human cancers. In: Doiron DR, Gomer CJ (eds)Porphyrin Localisation and Treatment of Tumours. New York: Alan Liss, 1984:693–708.
McCulloch GAJ, Forbes, IJ, Lee-See K et al. Phototherapy in malignant brain tumors. In: Doiron DR, Gomer CJ (eds)Porphyrin Localisation and Treatment of Tumours. New York: Alan Liss, 1984:709–12
Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoprophyrin IX: basic principles and present clinical experience.J Photochem Photobiol [B] 1990,6:143–8
Barr H, Krasner N, Boulos PB et al. Photodynamic therapy for colorectal cancer: a quantitative pilot study.Br J Surg 1990,77:93–6
McCaughan JS. Overview of experiences with photodynamic therapy for malignancy in 192 patients.Photochem Photobiol 1987,46:903–9
Gomer CJ. Yearly review: predinical examination of first and second generation photosensitisers used in photodynamic therapy.Photochem Photobiol 1991,54:1093–107
Noske DP, Wolbers JG, Sternberg HJCM. Review article: photodynamic therapy of malignant glioma.Clin Neurol Neurosurg 1991,93:293–307
Muller PJ, Wilson BC. Photodynamic therapy of malignant brain tumours.Lasers Med Sci 1990,5:242–52
Lui H, Andersen RR. Photodynamic therapy in dermatology: recent developments.Dermatol Clin 1993,11:1–13
Gomer GJ, Doiron DR, Rucker N et al. Action spectrum (620–645 nm) for hematoporphyrin, derivative induced cell killing.Photochem Photobiol 1984,39:365–8
Canti G, Lattuada D, Leroy F et al Action spectrum of photoactivated phthalocyanine AlS2Pc in tumor bearing mice.Anticancer Drugs 1992,3:139–42
West CML, Moore JV. Cell survival characteristics of a human colon adenocarcinoma cell line after photodynamic treatment: a comparison of photofrin II and TPPS.Int J Radiat Biol 1988,54:621–34
Roberts SA. DRFIT: a program for fitting radiation surviving models.Int J Radiat Biol 1990,57:1243–6
Ben-Hur E, Newman HC, Crane SW, Rosenthal I. Pulsed versus continuous wave 680 nm laser in photosensitization by chloroaluminium phthalocyanine tetrasulfonate.SPIE,847, New directions in Photodynamic Therapy, 1987:154–7
Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as a toxic agent in photoinactivation of a murine tumor.Cancer Res 1986,36:2326–9
Star WM, Marijnissen NP, van den Berg-Blok AE et al. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers.Cancer Res 1986,46:2532
Weiman TJ, Mang TS, Fingar VH et al. Effect of photodynamic therapy on blood flow in normal and tumour vessels.Surgery 1988,104:512–7